fitting module of the origin 8.1® software Search Results


fitc conjugated lotus tetragonolobus lectin  (Vector Laboratories)
96
Vector Laboratories fitc conjugated lotus tetragonolobus lectin
Treatment with T3 counteracts pathological growth in diabetes- and glucose-injured podocytes and cardiomyocytes and maintains cardiomyocytes cytoarchitecture (A and B) Representative images of Glepp1 (A) and WT1 (B) staining in kidney serial sections of lean and diabetic animals. Quantification of individual podocyte volume and WT1-positive podocytes in lean and ZDF rats (A and B, right). (C) Quantification of Feret’s diameter in cardiomyocytes. (D and E) Evaluation of DNA content in glomerular cells (D) and cardiomyocytes (E) of control and diabetic animals. (F) Representative images of 3D reconstructed kidney (top) and heart (bottom) tissue sections. Tissues were stained with rhodamine-labeled WGA <t>lectin.</t> (G–I) Quantification of cell area (G, H) and axis ratio (I) in control, glucose-injured, and T3-treated human podocytes (G) and cardiomyocytes (H, I). For quantification, representative images were randomly taken from different areas of cell culture. At least 91 cells from each group were analyzed from n = 3 independent experiments (G–I). Data are expressed as mean ± SEM, one-way ANOVA corrected with Tukey’s post hoc test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001. n = 5–6 animals per group. Scale bars, 20 μm (A, B), 40 μm (F).
Fitc Conjugated Lotus Tetragonolobus Lectin, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fitc conjugated lotus tetragonolobus lectin/product/Vector Laboratories
Average 96 stars, based on 1 article reviews
fitc conjugated lotus tetragonolobus lectin - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier
x100 software version 2 0 1  (GE Healthcare)
96
GE Healthcare x100 software version 2 0 1
Treatment with T3 counteracts pathological growth in diabetes- and glucose-injured podocytes and cardiomyocytes and maintains cardiomyocytes cytoarchitecture (A and B) Representative images of Glepp1 (A) and WT1 (B) staining in kidney serial sections of lean and diabetic animals. Quantification of individual podocyte volume and WT1-positive podocytes in lean and ZDF rats (A and B, right). (C) Quantification of Feret’s diameter in cardiomyocytes. (D and E) Evaluation of DNA content in glomerular cells (D) and cardiomyocytes (E) of control and diabetic animals. (F) Representative images of 3D reconstructed kidney (top) and heart (bottom) tissue sections. Tissues were stained with rhodamine-labeled WGA <t>lectin.</t> (G–I) Quantification of cell area (G, H) and axis ratio (I) in control, glucose-injured, and T3-treated human podocytes (G) and cardiomyocytes (H, I). For quantification, representative images were randomly taken from different areas of cell culture. At least 91 cells from each group were analyzed from n = 3 independent experiments (G–I). Data are expressed as mean ± SEM, one-way ANOVA corrected with Tukey’s post hoc test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001. n = 5–6 animals per group. Scale bars, 20 μm (A, B), 40 μm (F).
X100 Software Version 2 0 1, supplied by GE Healthcare, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/x100 software version 2 0 1/product/GE Healthcare
Average 96 stars, based on 1 article reviews
x100 software version 2 0 1 - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier
fitc ebioscience 11 0441 81 hba adult hemoglobin  (Thermo Fisher)
97
Thermo Fisher fitc ebioscience 11 0441 81 hba adult hemoglobin
Treatment with T3 counteracts pathological growth in diabetes- and glucose-injured podocytes and cardiomyocytes and maintains cardiomyocytes cytoarchitecture (A and B) Representative images of Glepp1 (A) and WT1 (B) staining in kidney serial sections of lean and diabetic animals. Quantification of individual podocyte volume and WT1-positive podocytes in lean and ZDF rats (A and B, right). (C) Quantification of Feret’s diameter in cardiomyocytes. (D and E) Evaluation of DNA content in glomerular cells (D) and cardiomyocytes (E) of control and diabetic animals. (F) Representative images of 3D reconstructed kidney (top) and heart (bottom) tissue sections. Tissues were stained with rhodamine-labeled WGA <t>lectin.</t> (G–I) Quantification of cell area (G, H) and axis ratio (I) in control, glucose-injured, and T3-treated human podocytes (G) and cardiomyocytes (H, I). For quantification, representative images were randomly taken from different areas of cell culture. At least 91 cells from each group were analyzed from n = 3 independent experiments (G–I). Data are expressed as mean ± SEM, one-way ANOVA corrected with Tukey’s post hoc test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001. n = 5–6 animals per group. Scale bars, 20 μm (A, B), 40 μm (F).
Fitc Ebioscience 11 0441 81 Hba Adult Hemoglobin, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fitc ebioscience 11 0441 81 hba adult hemoglobin/product/Thermo Fisher
Average 97 stars, based on 1 article reviews
fitc ebioscience 11 0441 81 hba adult hemoglobin - by Bioz Stars, 2026-06
97/100 stars
  Buy from Supplier
non-linear fitting module in graphpad prism 6.0 software  (GraphPad Software Inc)
90
GraphPad Software Inc non-linear fitting module in graphpad prism 6.0 software
Treatment with T3 counteracts pathological growth in diabetes- and glucose-injured podocytes and cardiomyocytes and maintains cardiomyocytes cytoarchitecture (A and B) Representative images of Glepp1 (A) and WT1 (B) staining in kidney serial sections of lean and diabetic animals. Quantification of individual podocyte volume and WT1-positive podocytes in lean and ZDF rats (A and B, right). (C) Quantification of Feret’s diameter in cardiomyocytes. (D and E) Evaluation of DNA content in glomerular cells (D) and cardiomyocytes (E) of control and diabetic animals. (F) Representative images of 3D reconstructed kidney (top) and heart (bottom) tissue sections. Tissues were stained with rhodamine-labeled WGA <t>lectin.</t> (G–I) Quantification of cell area (G, H) and axis ratio (I) in control, glucose-injured, and T3-treated human podocytes (G) and cardiomyocytes (H, I). For quantification, representative images were randomly taken from different areas of cell culture. At least 91 cells from each group were analyzed from n = 3 independent experiments (G–I). Data are expressed as mean ± SEM, one-way ANOVA corrected with Tukey’s post hoc test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001. n = 5–6 animals per group. Scale bars, 20 μm (A, B), 40 μm (F).
Non Linear Fitting Module In Graphpad Prism 6.0 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear fitting module in graphpad prism 6.0 software/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear fitting module in graphpad prism 6.0 software - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
prism 8 enzyme kinetics-inhibition module  (GraphPad Software Inc)
90
GraphPad Software Inc prism 8 enzyme kinetics-inhibition module
Treatment with T3 counteracts pathological growth in diabetes- and glucose-injured podocytes and cardiomyocytes and maintains cardiomyocytes cytoarchitecture (A and B) Representative images of Glepp1 (A) and WT1 (B) staining in kidney serial sections of lean and diabetic animals. Quantification of individual podocyte volume and WT1-positive podocytes in lean and ZDF rats (A and B, right). (C) Quantification of Feret’s diameter in cardiomyocytes. (D and E) Evaluation of DNA content in glomerular cells (D) and cardiomyocytes (E) of control and diabetic animals. (F) Representative images of 3D reconstructed kidney (top) and heart (bottom) tissue sections. Tissues were stained with rhodamine-labeled WGA <t>lectin.</t> (G–I) Quantification of cell area (G, H) and axis ratio (I) in control, glucose-injured, and T3-treated human podocytes (G) and cardiomyocytes (H, I). For quantification, representative images were randomly taken from different areas of cell culture. At least 91 cells from each group were analyzed from n = 3 independent experiments (G–I). Data are expressed as mean ± SEM, one-way ANOVA corrected with Tukey’s post hoc test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001. n = 5–6 animals per group. Scale bars, 20 μm (A, B), 40 μm (F).
Prism 8 Enzyme Kinetics Inhibition Module, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prism 8 enzyme kinetics-inhibition module/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
prism 8 enzyme kinetics-inhibition module - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
reghdfe module  (STATA Corporation)
99
STATA Corporation reghdfe module
Treatment with T3 counteracts pathological growth in diabetes- and glucose-injured podocytes and cardiomyocytes and maintains cardiomyocytes cytoarchitecture (A and B) Representative images of Glepp1 (A) and WT1 (B) staining in kidney serial sections of lean and diabetic animals. Quantification of individual podocyte volume and WT1-positive podocytes in lean and ZDF rats (A and B, right). (C) Quantification of Feret’s diameter in cardiomyocytes. (D and E) Evaluation of DNA content in glomerular cells (D) and cardiomyocytes (E) of control and diabetic animals. (F) Representative images of 3D reconstructed kidney (top) and heart (bottom) tissue sections. Tissues were stained with rhodamine-labeled WGA <t>lectin.</t> (G–I) Quantification of cell area (G, H) and axis ratio (I) in control, glucose-injured, and T3-treated human podocytes (G) and cardiomyocytes (H, I). For quantification, representative images were randomly taken from different areas of cell culture. At least 91 cells from each group were analyzed from n = 3 independent experiments (G–I). Data are expressed as mean ± SEM, one-way ANOVA corrected with Tukey’s post hoc test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001. n = 5–6 animals per group. Scale bars, 20 μm (A, B), 40 μm (F).
Reghdfe Module, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/reghdfe module/product/STATA Corporation
Average 99 stars, based on 1 article reviews
reghdfe module - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier
origin peak fitting module  (Malvern Panalytical)
86
Malvern Panalytical origin peak fitting module
Treatment with T3 counteracts pathological growth in diabetes- and glucose-injured podocytes and cardiomyocytes and maintains cardiomyocytes cytoarchitecture (A and B) Representative images of Glepp1 (A) and WT1 (B) staining in kidney serial sections of lean and diabetic animals. Quantification of individual podocyte volume and WT1-positive podocytes in lean and ZDF rats (A and B, right). (C) Quantification of Feret’s diameter in cardiomyocytes. (D and E) Evaluation of DNA content in glomerular cells (D) and cardiomyocytes (E) of control and diabetic animals. (F) Representative images of 3D reconstructed kidney (top) and heart (bottom) tissue sections. Tissues were stained with rhodamine-labeled WGA <t>lectin.</t> (G–I) Quantification of cell area (G, H) and axis ratio (I) in control, glucose-injured, and T3-treated human podocytes (G) and cardiomyocytes (H, I). For quantification, representative images were randomly taken from different areas of cell culture. At least 91 cells from each group were analyzed from n = 3 independent experiments (G–I). Data are expressed as mean ± SEM, one-way ANOVA corrected with Tukey’s post hoc test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001. n = 5–6 animals per group. Scale bars, 20 μm (A, B), 40 μm (F).
Origin Peak Fitting Module, supplied by Malvern Panalytical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/origin peak fitting module/product/Malvern Panalytical
Average 86 stars, based on 1 article reviews
origin peak fitting module - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
nonlinear regression with a one site binding module  (GraphPad Software Inc)
90
GraphPad Software Inc nonlinear regression with a one site binding module
Treatment with T3 counteracts pathological growth in diabetes- and glucose-injured podocytes and cardiomyocytes and maintains cardiomyocytes cytoarchitecture (A and B) Representative images of Glepp1 (A) and WT1 (B) staining in kidney serial sections of lean and diabetic animals. Quantification of individual podocyte volume and WT1-positive podocytes in lean and ZDF rats (A and B, right). (C) Quantification of Feret’s diameter in cardiomyocytes. (D and E) Evaluation of DNA content in glomerular cells (D) and cardiomyocytes (E) of control and diabetic animals. (F) Representative images of 3D reconstructed kidney (top) and heart (bottom) tissue sections. Tissues were stained with rhodamine-labeled WGA <t>lectin.</t> (G–I) Quantification of cell area (G, H) and axis ratio (I) in control, glucose-injured, and T3-treated human podocytes (G) and cardiomyocytes (H, I). For quantification, representative images were randomly taken from different areas of cell culture. At least 91 cells from each group were analyzed from n = 3 independent experiments (G–I). Data are expressed as mean ± SEM, one-way ANOVA corrected with Tukey’s post hoc test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001. n = 5–6 animals per group. Scale bars, 20 μm (A, B), 40 μm (F).
Nonlinear Regression With A One Site Binding Module, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear regression with a one site binding module/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
nonlinear regression with a one site binding module - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
incucytetm scratch wound cell migration software module  (Sartorius AG)
99
Sartorius AG incucytetm scratch wound cell migration software module
Treatment with T3 counteracts pathological growth in diabetes- and glucose-injured podocytes and cardiomyocytes and maintains cardiomyocytes cytoarchitecture (A and B) Representative images of Glepp1 (A) and WT1 (B) staining in kidney serial sections of lean and diabetic animals. Quantification of individual podocyte volume and WT1-positive podocytes in lean and ZDF rats (A and B, right). (C) Quantification of Feret’s diameter in cardiomyocytes. (D and E) Evaluation of DNA content in glomerular cells (D) and cardiomyocytes (E) of control and diabetic animals. (F) Representative images of 3D reconstructed kidney (top) and heart (bottom) tissue sections. Tissues were stained with rhodamine-labeled WGA <t>lectin.</t> (G–I) Quantification of cell area (G, H) and axis ratio (I) in control, glucose-injured, and T3-treated human podocytes (G) and cardiomyocytes (H, I). For quantification, representative images were randomly taken from different areas of cell culture. At least 91 cells from each group were analyzed from n = 3 independent experiments (G–I). Data are expressed as mean ± SEM, one-way ANOVA corrected with Tukey’s post hoc test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001. n = 5–6 animals per group. Scale bars, 20 μm (A, B), 40 μm (F).
Incucytetm Scratch Wound Cell Migration Software Module, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/incucytetm scratch wound cell migration software module/product/Sartorius AG
Average 99 stars, based on 1 article reviews
incucytetm scratch wound cell migration software module - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier
clampfit  (Danaher Inc)
96
Danaher Inc clampfit
Treatment with T3 counteracts pathological growth in diabetes- and glucose-injured podocytes and cardiomyocytes and maintains cardiomyocytes cytoarchitecture (A and B) Representative images of Glepp1 (A) and WT1 (B) staining in kidney serial sections of lean and diabetic animals. Quantification of individual podocyte volume and WT1-positive podocytes in lean and ZDF rats (A and B, right). (C) Quantification of Feret’s diameter in cardiomyocytes. (D and E) Evaluation of DNA content in glomerular cells (D) and cardiomyocytes (E) of control and diabetic animals. (F) Representative images of 3D reconstructed kidney (top) and heart (bottom) tissue sections. Tissues were stained with rhodamine-labeled WGA <t>lectin.</t> (G–I) Quantification of cell area (G, H) and axis ratio (I) in control, glucose-injured, and T3-treated human podocytes (G) and cardiomyocytes (H, I). For quantification, representative images were randomly taken from different areas of cell culture. At least 91 cells from each group were analyzed from n = 3 independent experiments (G–I). Data are expressed as mean ± SEM, one-way ANOVA corrected with Tukey’s post hoc test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001. n = 5–6 animals per group. Scale bars, 20 μm (A, B), 40 μm (F).
Clampfit, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clampfit/product/Danaher Inc
Average 96 stars, based on 1 article reviews
clampfit - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier
seqlogit module  (STATA Corporation)
99
STATA Corporation seqlogit module
Treatment with T3 counteracts pathological growth in diabetes- and glucose-injured podocytes and cardiomyocytes and maintains cardiomyocytes cytoarchitecture (A and B) Representative images of Glepp1 (A) and WT1 (B) staining in kidney serial sections of lean and diabetic animals. Quantification of individual podocyte volume and WT1-positive podocytes in lean and ZDF rats (A and B, right). (C) Quantification of Feret’s diameter in cardiomyocytes. (D and E) Evaluation of DNA content in glomerular cells (D) and cardiomyocytes (E) of control and diabetic animals. (F) Representative images of 3D reconstructed kidney (top) and heart (bottom) tissue sections. Tissues were stained with rhodamine-labeled WGA <t>lectin.</t> (G–I) Quantification of cell area (G, H) and axis ratio (I) in control, glucose-injured, and T3-treated human podocytes (G) and cardiomyocytes (H, I). For quantification, representative images were randomly taken from different areas of cell culture. At least 91 cells from each group were analyzed from n = 3 independent experiments (G–I). Data are expressed as mean ± SEM, one-way ANOVA corrected with Tukey’s post hoc test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001. n = 5–6 animals per group. Scale bars, 20 μm (A, B), 40 μm (F).
Seqlogit Module, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/seqlogit module/product/STATA Corporation
Average 99 stars, based on 1 article reviews
seqlogit module - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier
global curve fit module of prism 5.0a  (GraphPad Software Inc)
90
GraphPad Software Inc global curve fit module of prism 5.0a
Treatment with T3 counteracts pathological growth in diabetes- and glucose-injured podocytes and cardiomyocytes and maintains cardiomyocytes cytoarchitecture (A and B) Representative images of Glepp1 (A) and WT1 (B) staining in kidney serial sections of lean and diabetic animals. Quantification of individual podocyte volume and WT1-positive podocytes in lean and ZDF rats (A and B, right). (C) Quantification of Feret’s diameter in cardiomyocytes. (D and E) Evaluation of DNA content in glomerular cells (D) and cardiomyocytes (E) of control and diabetic animals. (F) Representative images of 3D reconstructed kidney (top) and heart (bottom) tissue sections. Tissues were stained with rhodamine-labeled WGA <t>lectin.</t> (G–I) Quantification of cell area (G, H) and axis ratio (I) in control, glucose-injured, and T3-treated human podocytes (G) and cardiomyocytes (H, I). For quantification, representative images were randomly taken from different areas of cell culture. At least 91 cells from each group were analyzed from n = 3 independent experiments (G–I). Data are expressed as mean ± SEM, one-way ANOVA corrected with Tukey’s post hoc test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001. n = 5–6 animals per group. Scale bars, 20 μm (A, B), 40 μm (F).
Global Curve Fit Module Of Prism 5.0a, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/global curve fit module of prism 5.0a/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
global curve fit module of prism 5.0a - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Treatment with T3 counteracts pathological growth in diabetes- and glucose-injured podocytes and cardiomyocytes and maintains cardiomyocytes cytoarchitecture (A and B) Representative images of Glepp1 (A) and WT1 (B) staining in kidney serial sections of lean and diabetic animals. Quantification of individual podocyte volume and WT1-positive podocytes in lean and ZDF rats (A and B, right). (C) Quantification of Feret’s diameter in cardiomyocytes. (D and E) Evaluation of DNA content in glomerular cells (D) and cardiomyocytes (E) of control and diabetic animals. (F) Representative images of 3D reconstructed kidney (top) and heart (bottom) tissue sections. Tissues were stained with rhodamine-labeled WGA lectin. (G–I) Quantification of cell area (G, H) and axis ratio (I) in control, glucose-injured, and T3-treated human podocytes (G) and cardiomyocytes (H, I). For quantification, representative images were randomly taken from different areas of cell culture. At least 91 cells from each group were analyzed from n = 3 independent experiments (G–I). Data are expressed as mean ± SEM, one-way ANOVA corrected with Tukey’s post hoc test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001. n = 5–6 animals per group. Scale bars, 20 μm (A, B), 40 μm (F).

Journal: iScience

Article Title: Thyroid hormone treatment counteracts cellular phenotypical remodeling in diabetic organs

doi: 10.1016/j.isci.2023.107826

Figure Lengend Snippet: Treatment with T3 counteracts pathological growth in diabetes- and glucose-injured podocytes and cardiomyocytes and maintains cardiomyocytes cytoarchitecture (A and B) Representative images of Glepp1 (A) and WT1 (B) staining in kidney serial sections of lean and diabetic animals. Quantification of individual podocyte volume and WT1-positive podocytes in lean and ZDF rats (A and B, right). (C) Quantification of Feret’s diameter in cardiomyocytes. (D and E) Evaluation of DNA content in glomerular cells (D) and cardiomyocytes (E) of control and diabetic animals. (F) Representative images of 3D reconstructed kidney (top) and heart (bottom) tissue sections. Tissues were stained with rhodamine-labeled WGA lectin. (G–I) Quantification of cell area (G, H) and axis ratio (I) in control, glucose-injured, and T3-treated human podocytes (G) and cardiomyocytes (H, I). For quantification, representative images were randomly taken from different areas of cell culture. At least 91 cells from each group were analyzed from n = 3 independent experiments (G–I). Data are expressed as mean ± SEM, one-way ANOVA corrected with Tukey’s post hoc test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001. n = 5–6 animals per group. Scale bars, 20 μm (A, B), 40 μm (F).

Article Snippet: FITC-conjugated lotus tetragonolobus lectin (LTL, 1:80 overnight at 4°C) (Cat# FL-1321-2, Vector Laboratories) was used to stain tubular structures when needed.

Techniques: Staining, Control, Labeling, Cell Culture

Journal: iScience

Article Title: Thyroid hormone treatment counteracts cellular phenotypical remodeling in diabetic organs

doi: 10.1016/j.isci.2023.107826

Figure Lengend Snippet:

Article Snippet: FITC-conjugated lotus tetragonolobus lectin (LTL, 1:80 overnight at 4°C) (Cat# FL-1321-2, Vector Laboratories) was used to stain tubular structures when needed.

Techniques: Recombinant, Plasmid Preparation, Membrane, Enzyme-linked Immunosorbent Assay, DC Protein Assay, Software